Trump Thanks India For Decision On Anti-Malaria Drug

President Donald Trump on Wednesday thanked India for its decision to increase exports of the anti-malaria drug hydroxychloroquine, an unproven treatment that Trump has promoted in the fight against the novel coronavirus.

India said on Tuesday it will allow some exports of hydroxychloroquine after Trump urged New Delhi to release supplies of the drug seen as a possible treatment for COVID-19.

“Extraordinary times require even closer cooperation between friends. Thank you India and the Indian people for the decision on HCQ. Will not be forgotten! Thank you Prime Minister @NarendraModi for your strong leadership in helping not just India, but humanity, in this fight!” Trump wrote on Twitter.

Recent Posts

  • Featured

A New World Order Is Here And This Is What It Looks Like

On Sept. 3, 2025, China celebrated the 80th anniversary of its victory over Japan by staging a carefully choreographed event…

1 day ago
  • Featured

11 Yrs After Fatal Floods, Kashmir Is Hit Again And Remains Unprepared

Since August 20, Jammu and Kashmir has been lashed by intermittent rainfall. Flash floods and landslides in the Jammu region…

2 days ago
  • Featured

A Beloved ‘Tree Of Life’ Is Vanishing From An Already Scarce Desert

The social, economic and cultural importance of the khejri tree in the Thar desert has earned it the title of…

2 days ago
  • Featured

Congress Labels PM Modi’s Ode To RSS Chief Bhagwat ‘Over-The-Top’

On Thursday, 11 September, the Congress party launched a sharp critique of Prime Minister Narendra Modi’s recent tribute to Rashtriya…

2 days ago
  • Featured

Renewable Energy Promotion Boosts Learning In Remote Island Schools

Solar panels provide reliable power supply to Assam’s island schools where grid power is hard to reach. With the help…

3 days ago
  • Featured

Are Cloudbursts A Scapegoat For Floods?

August was a particularly difficult month for the Indian Himalayan states of Uttarakhand, Himachal Pradesh and Jammu and Kashmir. Multiple…

3 days ago

This website uses cookies.